Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Automated analysis of PSMA-PET/CT studies using convolutional neural networks

View ORCID ProfileLars Edenbrandt, View ORCID ProfilePablo Borrelli, View ORCID ProfileJohannes Ulén, View ORCID ProfileOlof Enqvist, View ORCID ProfileElin Trägårdh
doi: https://doi.org/10.1101/2021.03.03.21252818
Lars Edenbrandt
aRegion Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Physiology, Gothenburg, Sweden
bDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lars Edenbrandt
  • For correspondence: lars.edenbrandt@gu.se
Pablo Borrelli
aRegion Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Physiology, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pablo Borrelli
Johannes Ulén
cEigenvision AB, Malmö, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johannes Ulén
Olof Enqvist
cEigenvision AB, Malmö, Sweden
dDepartment of Electrical Engineering, Chalmers University of Technology, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olof Enqvist
Elin Trägårdh
eDepartment of Translational Medicine and Wallenberg Center for Molecular Medicine, Lund University, Malmö, Sweden
fDepartment of Clinical Physiology and Nuclear Medicine, Skåne University Hospital, Malmö, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elin Trägårdh
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose Prostate-specific membrane antigen (PSMA) PET/CT has shown to be more sensitive and accurate than conventional imaging. Visual interpretation of the images causes both intra- and inter-reader disagreement and there is therefore a need for objective methods to analyze the images. The aim of this study was to develop an artificial intelligence (AI) tool for PSMA PET/CT and to evaluate the influence of the tool on inter-reader variability.

Approach We have recently trained AI tools to automatically segment organs, detect tumors, and quantify volume and tracer uptake of tumors in PET/CT. The primary prostate gland tumor, bone metastases, and lymph nodes were analyzed in patients with prostate cancer. These studies were based on non-PSMA targeting PET tracers. In this study an AI tool for PSMA PET/CT was developed based on our previous AI tools. Letting three physicians analyze ten PSMA PET/CT studies first without support from the AI tool and at a second occasion with the support of the AI tool assessed the influence of the tool. A two-sided sign test was used to analyze the number of cases with increased and decreased variability with support of the AI tool.

Results The range between the physicians in prostate tumor total lesion uptake (TLU) decreased for all ten patients with AI support (p=0.002) and decreased in bone metastases TLU for nine patients and increased in one patient (p=0.01). Regarding the number of detected lymph nodes the physicians agreed in on average 72% of the lesions without AI support and this number decreased to 65% with AI support.

Conclusions Physicians supported by an AI tool for automated analysis of PSMA-PET/CT studies showed significantly less inter-reader variability in the quantification of primary prostate tumors and bone metastases than when performing a completely manual analysis. A similar effect was not found for lymph node lesions. The tool may facilitate comparisons of studies from different centers, pooling data within multicenter trials and performing meta-analysis. We invite researchers to apply and evaluate our AI tool for their PSMA PET/CT studies. The AI tool is therefore available upon reasonable request for research purposes at www.recomia.org.

Competing Interest Statement

Edenbrandt reports grants from EXINI diagnostics AB, Lund, Sweden outside the submitted work until August 2020. Edenbrandt was employed as Scientific Director by EXINI Diagnostics AB (Lund, Sweden) until May 2020. Borrelli works as consultant for EXINI Diagnostics AB (Lund, Sweden).

Funding Statement

The study was financed by grants from the Knut and Alice Wallenberg foundation, the Medical Faculty at Lund University, Region Skane and the Swedish state under the agreement between Swedish government and the county councils, the ALF-agreement (ALFGBG-720751).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted according to the principles expressed in the Declaration of Helsinki, and approved by the local research ethics committee at Lund University (#2016/193 and #2018/753). All patients provided written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The AI tool and data presented in this study is available upon reasonable request for research purposes at www.recomia.org.

https://www.recomia.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 05, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Automated analysis of PSMA-PET/CT studies using convolutional neural networks
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Automated analysis of PSMA-PET/CT studies using convolutional neural networks
Lars Edenbrandt, Pablo Borrelli, Johannes Ulén, Olof Enqvist, Elin Trägårdh
medRxiv 2021.03.03.21252818; doi: https://doi.org/10.1101/2021.03.03.21252818
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Automated analysis of PSMA-PET/CT studies using convolutional neural networks
Lars Edenbrandt, Pablo Borrelli, Johannes Ulén, Olof Enqvist, Elin Trägårdh
medRxiv 2021.03.03.21252818; doi: https://doi.org/10.1101/2021.03.03.21252818

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Radiology and Imaging
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1240)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10023)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2281)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4834)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)